Ranirestat + Placebo
Phase 2/3Completed 0 views this week 0 watching💤 Quiet
Interest: 38/100
38
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Mild to Moderate Diabetic Sensorimotor Polyneuropathy
Conditions
Mild to Moderate Diabetic Sensorimotor Polyneuropathy
Trial Timeline
Jul 1, 2009 → Feb 1, 2013
NCT ID
NCT00927914About Ranirestat + Placebo
Ranirestat + Placebo is a phase 2/3 stage product being developed by Eisai for Mild to Moderate Diabetic Sensorimotor Polyneuropathy. The current trial status is completed. This product is registered under clinical trial identifier NCT00927914. Target conditions include Mild to Moderate Diabetic Sensorimotor Polyneuropathy.
What happened to similar drugs?
8 of 17 similar drugs in Mild to Moderate Diabetic Sensorimotor Polyneuropathy were approved
Approved (8) Terminated (2) Active (8)
Hype Score Breakdown
Clinical
15
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00927914 | Phase 2/3 | Completed |
Competing Products
20 competing products in Mild to Moderate Diabetic Sensorimotor Polyneuropathy